Skip to main content
MedPathMedPath Home
Clinical Trials/NCT03818503
NCT03818503
Recruiting
N/A

E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe

European Organisation for Research and Treatment of Cancer - EORTC77 sites in 12 countries2,000 target enrollmentJune 24, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cancer
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Enrollment
2000
Locations
77
Primary Endpoint
Number of patients treated with radiotherapy enrolled in the program
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The primary objective is the collection of real-world data of cancer patients treated with radiotherapy, to support radiotherapy research and to provide evidence of the role of radiation oncology in a multidisciplinary approach. This is an open ended prospective non-interventional non-therapeutic multi-cohort study.

Registry
clinicaltrials.gov
Start Date
June 24, 2019
End Date
April 30, 2026
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Pathologically confirmed cancer.
  • •Written informed consent for E²-RADIatE according to applicable legal and ethical requirements
  • •Planned use of radiotherapy
  • •Eligibility of the patient confirmed for at least one cohort confirmed
  • •Patients of 12 years and older

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Number of patients treated with radiotherapy enrolled in the program

Time Frame: 5 years

Secondary Outcomes

  • Distant metastasis free survival(5 years)
  • Disease free survival(5 years)
  • Loco-regional control(5 years)
  • Incidence of adverse events related to radiotherapy(5 years)
  • Overall survival(5 years)

Study Sites (77)

Loading locations...

Similar Trials

Active, Not Recruiting
N/A
Chemo-radiotherapy as Main Treatment Strategy for Rectal Cancer. Can we Provide a More Precise and Effective TreatmentRectal CancerRectal AdenocarcinomaLocally Advanced Malignant Neoplasm
NCT03619668Aalborg University Hospital16
Recruiting
N/A
Patient Experience Data in Radiation OncologyRadiotherapy Side EffectPROMs
NCT05224297Medical University of Vienna6,000
Active, Not Recruiting
N/A
Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking StudySolid TumorsHematologic Malignancies
NCT02457962Mayo Clinic15,000
Terminated
N/A
CARE: A Prospective Multicenter Case Study to Assess Radiation Exposure in Patients Treated With the Penumbra Coil 400Intracranial Aneurysms
NCT02122133Penumbra Inc.67
Unknown
N/A
TARGeted Intraoperative radioTherapy (TARGIT) Registry DatabaseEarly-Stage Breast Carcinoma
NCT02947425University College, London2,000